OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Dianne Perez

2 Projects | 1 Researchers | $2,322,783 Invested

2023

Cleveland Clinic Foundation

Dianne Perez, PhD

IND-Enabling Studies for a Novel Positive Allosteric Modulator of the Alpha1A-Adrenergic Receptor to Treat Alzheimer’s Disease

  • Funding Amount: $1,828,343
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Active

2018

Cleveland Clinic Foundation

Dianne Perez, PhD

Optimization of Novel Positive Allosteric Modulators of the Alpha1A-Adrenergic Receptor to treat Alzheimer's Disease

  • Funding Amount: $494,440
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed